In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus
| Autor: | 'T Hart, L. M., Fritsche, A., Nijpels, G., Van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., Van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., MacHicao, F., Willemsen, G., Heine, R. J., Kramer, M. H., Holst, J. J., De Koning, E. J., Häring, H. U., Pedersen, O., Groop, L., De Geus, E. J., Slagboom, P. E., Boomsma, D. I., Eekhoff, E. M., Pearson, E. R., Diamant, M. |
|---|---|
| Přispěvatelé: | Epidemiology and Data Science, General practice, EMGO - Lifestyle, overweight and diabetes, Dermatology, CCA - Immuno-pathogenesis, Internal medicine, ICaR - Circulation and metabolism, ICaR - Ischemia and repair, MOVE Research Institute |
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Zdroj: | Diabetes Technology and Therapeutics, 17, S131-S133. Mary Ann Liebert Inc. 'T Hart, L M, Fritsche, A, Nijpels, G, Van Leeuwen, N, Donnelly, L A, Dekker, J M, Alssema, M, Fadista, J, Carlotti, F, Gjesing, A P, Palmer, C N, Van Haeften, T W, Herzberg-Schäfer, S A, Simonis-Bik, A M, Houwing-Duistermaat, J J, Helmer, Q, Deelen, J, Guigas, B, Hansen, T, MacHicao, F, Willemsen, G, Heine, R J, Kramer, M H, Holst, J J, De Koning, E J, Häring, H U, Pedersen, O, Groop, L, De Geus, E J, Slagboom, P E, Boomsma, D I, Eekhoff, E M, Pearson, E R & Diamant, M 2015, ' In vivo efficacy of HD0471953 : A novel GPR119 agonist for the treatment of type 2 diabetes mellitus ', Diabetes Technology and Therapeutics, vol. 17, pp. S131-S133 . https://doi.org/10.1089/dia.2015.1514 |
| ISSN: | 1520-9156 |
| DOI: | 10.1089/dia.2015.1514 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|